Aldeyra Therapeutics (NASDAQ: ALDX) is a clinical-stage biopharmaceutical company focused on developing therapies for immune-mediated and metabolic diseases. The filing excerpts provided do not contain sufficient detail to describe its revenue model, product pipeline, competitive position, geographic footprint, leadership, or financial structure. Based solely on the available filing content, no further factual claims can be supported.

Source: SEC 10-K, filed 2026-02-27

Industry: Pharmaceutical Preparations Peers: ALPINE IMMUNE SCIENCES, INC. MiMedx Group Inc Atara Biotherapeutics Inc Biomea Fusion Inc BioXcel Therapeutics Inc Foghorn Therapeutics Inc Omega Therapeutics, Inc. Prelude Therapeutics Inc Tyra Biosciences Inc